Piramal Of India To Use Generics Sale To Fund First Drug Development
This article was originally published in PharmAsia News
India's Piramal, which is selling its generics business, plans to use part of the funds to produce India's first locally developed drug by 2012
You may also be interested in...
The company will invest $1.2bn over the next four years to expand and upgrade its manufacturing capacity for pre-fillable syringes and advanced drug delivery systems across seven manufacturing facilities.
Beneficiaries in nursing homes and in rural areas will benefit from a telehealth expansion in the final CMS physician fee schedule rule.
The data compares the sensitivity of almost 200 diagnostics against a standardized set of samples.